Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2013-03-11 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings
2013-03-11 Danish
Regulatory Filings 2013
Regulatory Filings Classification · 100% confidence The document is a press release dated March 11, 2013, announcing that ALK's partner, Merck & Co., Inc. (MSD), has submitted a marketing authorization application to the US FDA for a ragweed allergy tablet vaccine. This announcement details a significant event related to product development, regulatory submission, and partnership milestones, including an associated milestone payment of USD 5 million to ALK. This type of announcement, focusing on regulatory progress and partnership financial triggers rather than comprehensive financial results (like 10-K or IR) or management changes, fits best under Capital/Financing Update (CAP) due to the explicit mention of a milestone payment triggering a financial event, or potentially Regulatory Filings (RNS) as a general announcement. However, since the core news is the submission leading to a financial trigger (milestone payment), CAP is a strong candidate. Given the context of partnership development and milestone payments, it is most closely aligned with 'Capital/Financing Update' (CAP) as it directly relates to capital received from a strategic agreement, although it is also a regulatory event. Since it is a specific announcement about a partnership milestone payment, CAP is more precise than the general RNS fallback. The document length is short (3926 chars) and it is an announcement, not the full regulatory filing itself.
2013-03-11 Danish
Board/Management Information 2013
Board/Management Information Classification · 98% confidence The document is a short announcement dated March 5, 2013, from ALK-Abelló A/S. The text explicitly discusses the nomination of Jakob Riis for re-election to the board of directors at the upcoming general meeting (generalforsamling) on March 12, 2013, and the non-re-election of another member, Lars Holmqvist. This content directly relates to changes in the composition of the board of directors and management structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a full AGM presentation (AGM-R), nor is it a general proxy solicitation (PSI), but specifically about board nominations.
2013-03-05 Danish
Board/Management Information 2013
Board/Management Information Classification · 98% confidence The document is a short company release (Company release No 6/2013) dated March 5, 2013. The primary subject is the proposal of a new board member (Jakob Riis) for election at the upcoming Annual General Meeting (AGM) scheduled for March 12, 2013. It also mentions the reason why another member is not seeking re-election. This content directly relates to the composition and proposed changes to the Board of Directors, which falls under 'Board/Management Information' (MANG). While it mentions the AGM, the core focus is the management/board change proposal, not the AGM materials themselves (AGM-R) or the voting results (DVA).
2013-03-05 English
Director's Dealing 2013
Director's Dealing Classification · 99% confidence The document is a formal notification, indicated by the structure and the reference to 'værdipapirhandelslovens § 28a' (Securities Trading Act § 28a). It details transactions ('Transaktion: Køb') involving shares of ALK-Abelló A/S made by a leading employee/board member ('Navn: Lars Holmqvist', 'Årsag: Bestyrelsesmedlem'). This precisely matches the definition of Director's Dealing (insider trades). Filing Code: DIRS.
2013-02-18 Danish
Director's Dealing 2013
Director's Dealing Classification · 99% confidence The document is titled 'Report on transactions with ALK-Abelló A/S B-shares by managerial staff and their related parties' and explicitly details a 'Purchase' transaction of shares by a 'Member of the Board of Directors' (Lars Holmqvist) on a specific trading date. This directly corresponds to the definition of Director's Dealing, which reports personal share transactions by company directors and executives.
2013-02-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.